| Year |
Citation |
Score |
| 2023 |
Bergh S, Gabery S, Tonetto S, Kirik D, Petersén Å, Cheong RY. Effects of mutant huntingtin in oxytocin neurons on non-motor features of Huntington's disease. Neuropathology and Applied Neurobiology. e12891. PMID 36776123 DOI: 10.1111/nan.12891 |
0.731 |
|
| 2022 |
Bergh S, Cheong RY, Petersén Å, Gabery S. Oxytocin in Huntington's disease and the spectrum of amyotrophic lateral sclerosis-frontotemporal dementia. Frontiers in Molecular Neuroscience. 15: 984317. PMID 36187357 DOI: 10.3389/fnmol.2022.984317 |
0.729 |
|
| 2022 |
Dickson E, Soylu-Kucharz R, Petersén Å, Björkqvist M. Hypothalamic expression of huntingtin causes distinct metabolic changes in Huntington's disease mice. Molecular Metabolism. 101439. PMID 35007790 DOI: 10.1016/j.molmet.2022.101439 |
0.326 |
|
| 2021 |
Henningsen JB, Soylu-Kucharz R, Björkqvist M, Petersén Å. Effects of excitotoxicity in the hypothalamus in transgenic mouse models of Huntington disease. Heliyon. 7: e07808. PMID 34458633 DOI: 10.1016/j.heliyon.2021.e07808 |
0.311 |
|
| 2021 |
Gabery S, Kwa JE, Cheong RY, Baldo B, Ferrari Bardile C, Tan B, McLean C, Georgiou-Karistianis N, Poudel GR, Halliday G, Pouladi MA, Petersén Å. Early white matter pathology in the fornix of the limbic system in Huntington disease. Acta Neuropathologica. PMID 34448021 DOI: 10.1007/s00401-021-02362-8 |
0.728 |
|
| 2021 |
Gabery S, Ahmed RM, Caga J, Kiernan MC, Halliday GM, Petersén Å. Loss of the metabolism and sleep regulating neuronal populations expressing orexin and oxytocin in the hypothalamus in amyotrophic lateral sclerosis. Neuropathology and Applied Neurobiology. PMID 33755993 DOI: 10.1111/nan.12709 |
0.729 |
|
| 2020 |
Fjalldal S, Rylander L, van Westen D, Holmer H, Follin C, Gabery S, Petersen Å, Erfurth EM. Brain white matter lesions are associated with reduced hypothalamic volume and cranial radiotherapy in childhood-onset craniopharyngioma. Clinical Endocrinology. PMID 32762072 DOI: 10.1111/cen.14307 |
0.679 |
|
| 2020 |
Cheong RY, Tonetto S, von Hörsten S, Petersén Å. Imbalance of the oxytocin-vasopressin system contributes to the neuropsychiatric phenotype in the BACHD mouse model of Huntington disease. Psychoneuroendocrinology. 119: 104773. PMID 32590293 DOI: 10.1016/J.Psyneuen.2020.104773 |
0.377 |
|
| 2019 |
Petersén Å, Weydt P. The psychopharmacology of Huntington disease. Handbook of Clinical Neurology. 165: 179-189. PMID 31727211 DOI: 10.1016/B978-0-444-64012-3.00010-1 |
0.36 |
|
| 2019 |
Cheong RY, Gabery S, Petersén Å. The Role of Hypothalamic Pathology for Non-Motor Features of Huntington's Disease. Journal of Huntington's Disease. PMID 31594240 DOI: 10.3233/Jhd-190372 |
0.761 |
|
| 2018 |
Weydt P, Dupuis L, Petersen Å. Thermoregulatory disorders in Huntington disease. Handbook of Clinical Neurology. 157: 761-775. PMID 30459039 DOI: 10.1016/B978-0-444-64074-1.00047-1 |
0.359 |
|
| 2018 |
Dupuis L, Petersen Å, Weydt P. Thermoregulation in amyotrophic lateral sclerosis. Handbook of Clinical Neurology. 157: 749-760. PMID 30459038 DOI: 10.1016/B978-0-444-64074-1.00046-X |
0.344 |
|
| 2018 |
Ast A, Buntru A, Schindler F, Hasenkopf R, Schulz A, Brusendorf L, Klockmeier K, Grelle G, McMahon B, Niederlechner H, Jansen I, Diez L, Edel J, Boeddrich A, Franklin SA, et al. mHTT Seeding Activity: A Marker of Disease Progression and Neurotoxicity in Models of Huntington's Disease. Molecular Cell. 71: 675-688.e6. PMID 30193095 DOI: 10.1016/J.Molcel.2018.07.032 |
0.378 |
|
| 2018 |
Fjalldal S, Follin C, Gabery S, Sundgren PC, Björkman-Burtscher IM, Lätt J, Mannfolk P, Nordström CH, Rylander L, Ekman B, Cheong R, Pålsson A, Petersén Å, Erfurth EM. Detailed assessment of hypothalamic damage in craniopharyngioma patients with obesity. International Journal of Obesity (2005). PMID 30181653 DOI: 10.1038/S41366-018-0185-Z |
0.689 |
|
| 2018 |
Siebzehnrübl FA, Raber KA, Urbach YK, Schulze-Krebs A, Canneva F, Moceri S, Habermeyer J, Achoui D, Gupta B, Steindler DA, Stephan M, Nguyen HP, Bonin M, Riess O, Bauer A, et al. Early postnatal behavioral, cellular, and molecular changes in models of Huntington disease are reversible by HDAC inhibition. Proceedings of the National Academy of Sciences of the United States of America. PMID 30150378 DOI: 10.1073/Pnas.1807962115 |
0.68 |
|
| 2018 |
Pircs K, Petri R, Madsen S, Brattås PL, Vuono R, Ottosson DR, St-Amour I, Hersbach BA, Matusiak-Brückner M, Lundh SH, Petersén Å, Déglon N, Hébert SS, Parmar M, Barker RA, et al. Huntingtin Aggregation Impairs Autophagy, Leading to Argonaute-2 Accumulation and Global MicroRNA Dysregulation. Cell Reports. 24: 1397-1406. PMID 30089251 DOI: 10.1016/J.Celrep.2018.07.017 |
0.344 |
|
| 2018 |
Baldo B, Gabery S, Soylu-Kucharz R, Cheong RY, Henningsen JB, Englund E, McLean C, Kirik D, Halliday G, Petersén Å. SIRT1 is increased in affected brain regions and hypothalamic metabolic pathways are altered in Huntington disease. Neuropathology and Applied Neurobiology. PMID 30019499 DOI: 10.1111/Nan.12514 |
0.742 |
|
| 2018 |
Fjalldal S, Follin C, Svärd D, Rylander L, Gabery S, Petersen Å, Van Westen D, Sundgren P, Bjorkman-Burtscher I, Lätt J, Ekman B, Johanson A, Erfurth EM. Microstructural white matter alterations and hippocampal volumes are associated with cognitive deficits in craniopharyngioma. European Journal of Endocrinology. PMID 29599407 DOI: 10.1530/Eje-18-0081 |
0.702 |
|
| 2018 |
Vercruysse P, Vieau D, Blum D, Petersén Å, Dupuis L. Hypothalamic Alterations in Neurodegenerative Diseases and Their Relation to Abnormal Energy Metabolism. Frontiers in Molecular Neuroscience. 11: 2. PMID 29403354 DOI: 10.3389/Fnmol.2018.00002 |
0.421 |
|
| 2018 |
Gabery S, Baldo B, Soylu-Kucharz R, Cheong RY, Henningsen JB, Englund E, McLean C, Kirik D, Halliday G, Petersén Å. A52 SIRT1 is increased in affected brain regions in huntington disease impacting hypothalamic metabolic pathways Journal of Neurology, Neurosurgery, and Psychiatry. 89. DOI: 10.1136/Jnnp-2018-Ehdn.50 |
0.755 |
|
| 2018 |
Cheong RY, Cuellar-Baena S, Baldo B, Zandt Ri‘, Kirik D, Petersén Å. A44 Analysis of the deletion of mutant huntingtin from A2A-receptor expressing neurons Journal of Neurology, Neurosurgery, and Psychiatry. 89. DOI: 10.1136/Jnnp-2018-Ehdn.42 |
0.395 |
|
| 2017 |
Follin C, Fjalldal S, Svärd D, van Westen D, Gabery S, Petersén Å, Lätt J, Rylander L, Erfurth EM. Microstructure alterations in the Hypothalamus in cranially radiated Childhood Leukemia survivors but not in Craniopharyngioma patients unaffected by hypothalamic damage. Clinical Endocrinology. PMID 28502079 DOI: 10.1111/Cen.13373 |
0.694 |
|
| 2017 |
Gorges M, Vercruysse P, Müller HP, Huppertz HJ, Rosenbohm A, Nagel G, Petersen A, Ludolph AC, Dupuis L, Kassubek J. P 5 Volumetric analysis of the hypothalamus in a large cohort of patient with amyotrophic lateral sclerosis Clinical Neurophysiology. 128. DOI: 10.1016/J.Clinph.2017.06.084 |
0.355 |
|
| 2016 |
Kirik D, Cederfjäll E, Halliday G, Petersén Å. Gene therapy for Parkinson's disease: Disease modification by GDNF family of ligands. Neurobiology of Disease. PMID 27616425 DOI: 10.1016/J.Nbd.2016.09.008 |
0.313 |
|
| 2016 |
Soylu-Kucharz R, Baldo B, Petersén Å. Metabolic and behavioral effects of mutant huntingtin deletion in Sim1 neurons in the BACHD mouse model of Huntington's disease. Scientific Reports. 6: 28322. PMID 27334347 DOI: 10.1038/Srep28322 |
0.384 |
|
| 2016 |
Baker CR, Domínguez D JF, Stout JC, Gabery S, Churchyard A, Chua P, Egan GF, Petersén Å, Georgiou-Karistianis N, Poudel GR. Subjective sleep problems in Huntington's disease: A pilot investigation of the relationship to brain structure, neurocognitive, and neuropsychiatric function. Journal of the Neurological Sciences. 364: 148-53. PMID 27084236 DOI: 10.1016/J.Jns.2016.03.021 |
0.697 |
|
| 2016 |
Wagner L, Björkqvist M, Hult Lundh S, Wolf R, Börgel A, Schlenzig D, Ludwig HH, Rahfeld JU, Leavitt B, Demuth HU, Petersén Å, von Hörsten S. Neuropeptide Y (NPY) in cerebrospinal fluid from patients with Huntington's Disease: increased NPY levels and differential degradation of the NPY1-30 fragment. Journal of Neurochemistry. PMID 27016395 DOI: 10.1111/Jnc.13624 |
0.335 |
|
| 2016 |
Follin C, Gabery S, Petersén Å, Sundgren PC, Björkman-Burtcher I, Lätt J, Mannfolk P, Erfurth EM. Associations between Metabolic Risk Factors and the Hypothalamic Volume in Childhood Leukemia Survivors Treated with Cranial Radiotherapy. Plos One. 11: e0147575. PMID 26824435 DOI: 10.1371/Journal.Pone.0147575 |
0.707 |
|
| 2016 |
Follin C, Gabery S, Petersén Å, Sundgren PC, Björkman-Burtcher I, Lätt J, Mannfolk P, Erfurth EM. Associations between metabolic risk factors and the hypothalamic volume in childhood leukemia survivors treated with cranial radiotherapy Plos One. 11. DOI: 10.1371/journal.pone.0147575 |
0.69 |
|
| 2015 |
Soylu-Kucharz R, Adlesic N, Baldo B, Kirik D, Petersén Å. Hypothalamic overexpression of mutant huntingtin causes dysregulation of brown adipose tissue. Scientific Reports. 5: 14598. PMID 26419281 DOI: 10.1038/Srep14598 |
0.385 |
|
| 2015 |
Gabery S, Halliday G, Kirik D, Englund E, Petersén Å. Selective loss of oxytocin and vasopressin in the hypothalamus in early Huntington disease: a case study. Neuropathology and Applied Neurobiology. PMID 25765897 DOI: 10.1111/Nan.12236 |
0.712 |
|
| 2015 |
Wiesner D, Sinniger J, Henriques A, Dieterlé S, Müller HP, Rasche V, Ferger B, Dirrig-Grosch S, Soylu-Kucharz R, Petersén A, Walther P, Linkus B, Kassubek J, Wong PC, Ludolph AC, et al. Low dietary protein content alleviates motor symptoms in mice with mutant dynactin/dynein-mediated neurodegeneration. Human Molecular Genetics. 24: 2228-40. PMID 25552654 DOI: 10.1093/Hmg/Ddu741 |
0.345 |
|
| 2014 |
Baldo B, Cheong RY, Petersén Å. Effects of deletion of mutant huntingtin in steroidogenic factor 1 neurons on the psychiatric and metabolic phenotype in the BACHD mouse model of Huntington disease. Plos One. 9: e107691. PMID 25271967 DOI: 10.1371/Journal.Pone.0107691 |
0.443 |
|
| 2014 |
Hyrskyluoto A, Bruelle C, Lundh SH, Do HT, Kivinen J, Rappou E, Reijonen S, Waltimo T, Petersén Å, Lindholm D, Korhonen L. Ubiquitin-specific protease-14 reduces cellular aggregates and protects against mutant huntingtin-induced cell degeneration: involvement of the proteasome and ER stress-activated kinase IRE1α. Human Molecular Genetics. 23: 5928-39. PMID 24951540 DOI: 10.1093/Hmg/Ddu317 |
0.324 |
|
| 2014 |
Cheong R, Hult Lundh S, Kirik D, Petersen A. C09 The Psychiatric And Metabolic Phenotype Of The Bachd Mouse Model Of Huntington Disease Journal of Neurology, Neurosurgery & Psychiatry. 85: A28-A28. DOI: 10.1136/Jnnp-2014-309032.82 |
0.38 |
|
| 2014 |
Gabery S, Soylu-Kucharz R, McLean C, Kirik D, Halliday G, Petersen A. H04 Gene Expression Changes In Emotion And Metabolism Regulating Neuropeptide Systems In The Hypothalamus In Clinical Huntington Disease Journal of Neurology, Neurosurgery & Psychiatry. 85: A53-A53. DOI: 10.1136/Jnnp-2014-309032.149 |
0.753 |
|
| 2012 |
Petersén A, Gabery S. Hypothalamic and Limbic System Changes in Huntington's Disease. Journal of Huntington's Disease. 1: 5-16. PMID 25063186 DOI: 10.3233/Jhd-2012-120006 |
0.756 |
|
| 2012 |
Sajjad M, Pinard G, Fafard C, Illy C, Petersén Å, Kirik D. F01 Establishment of novel assays for quantification of full-length wild-type and mutant huntingtin by using the alphalisa technology Journal of Neurology, Neurosurgery & Psychiatry. 83: A21.2-A21. DOI: 10.1136/Jnnp-2012-303524.66 |
0.327 |
|
| 2012 |
Gabery S, Sajjad M, Hult S, Soylu R, Kirik D, Petersén Å. C09 Characterisation of a rat model of Huntington's disease based on targeted expression of a mutant huntingtin fragment in the forebrain using an adeno-associated viral vector Journal of Neurology, Neurosurgery & Psychiatry. 83: A18.1-A18. DOI: 10.1136/Jnnp-2012-303524.56 |
0.736 |
|
| 2012 |
Soylu R, Petersén Å. B31 Deletion of mutant huntingtin expression in sim1 neurons in the BACHD mouse model of Huntington's disease Journal of Neurology, Neurosurgery & Psychiatry. 83: A15.1-A15. DOI: 10.1136/Jnnp-2012-303524.47 |
0.402 |
|
| 2012 |
Hult S, Soylu R, Petersén Å. B30 Expression of mutant huntingtin in leptin receptor-expressing neurons does not influence the metabolic phenotype and psychiatric-like features in Huntington's disease Journal of Neurology, Neurosurgery & Psychiatry. 83: A14.3-A15. DOI: 10.1136/Jnnp-2012-303524.46 |
0.404 |
|
| 2011 |
Piguet O, Petersén A, Yin Ka Lam B, Gabery S, Murphy K, Hodges JR, Halliday GM. Eating and hypothalamus changes in behavioral-variant frontotemporal dementia. Annals of Neurology. 69: 312-9. PMID 21387376 DOI: 10.1002/Ana.22244 |
0.73 |
|
| 2010 |
Halliday G, Petersén Å, Piguet O. Neuropeptide And Hypothalamus Changes In Frontotemporal Dementia And Huntington'S Disease Journal of Neurochemistry. 115: 1-1. PMID 21182593 DOI: 10.1111/J.1471-4159.2010.06942.X |
0.326 |
|
| 2010 |
Braunstein KE, Eschbach J, Ròna-Vörös K, Soylu R, Mikrouli E, Larmet Y, René F, Gonzalez De Aguilar JL, Loeffler JP, Müller HP, Bucher S, Kaulisch T, Niessen HG, Tillmanns J, Fischer K, ... ... Petersen A, et al. A point mutation in the dynein heavy chain gene leads to striatal atrophy and compromises neurite outgrowth of striatal neurons. Human Molecular Genetics. 19: 4385-98. PMID 20807776 DOI: 10.1093/Hmg/Ddq361 |
0.378 |
|
| 2010 |
Petersén å. The Role of Hypothalamic and Neuroendocrine Changes in the Pathogenesis of Huntington’s Disease - Current Understanding and Implications for Future Treatments European Neurological Review. 5: 49. DOI: 10.17925/Enr.2010.05.02.49 |
0.31 |
|
| 2010 |
Hult S, Soylu R, Kirik D, Petersén Å. A25 Psychiatric and metabolic changes in the BACHD mouse model of Huntington's disease Journal of Neurology, Neurosurgery & Psychiatry. 81: A8.2-A8. DOI: 10.1136/Jnnp.2010.222570.25 |
0.396 |
|
| 2010 |
Soylu R, Hult S, Björklund T, Belgardt BF, Mauer J, Brüning JC, Kirik D, Petersén Å. A24 Hypothalamic expression of mutant huntingtin causes metabolic disturbances in mice Journal of Neurology, Neurosurgery & Psychiatry. 81: A8.1-A8. DOI: 10.1136/Jnnp.2010.222570.24 |
0.694 |
|
| 2010 |
Gabery S, Murphy K, Schultz K, Loy CT, McCusker E, Kirik D, Halliday G, Petersén Å. A23 Changes in key hypothalamic neuropeptide populations in Huntington's Disease revealed by neuropathological analyses Journal of Neurology, Neurosurgery, and Psychiatry. 81. DOI: 10.1136/Jnnp.2010.222570.23 |
0.771 |
|
| 2008 |
Araújo IM, Gil JM, Carreira BP, Mohapel P, Petersen A, Pinheiro PS, Soulet D, Bahr BA, Brundin P, Carvalho CM. Calpain activation is involved in early caspase-independent neurodegeneration in the hippocampus following status epilepticus. Journal of Neurochemistry. 105: 666-76. PMID 18088374 DOI: 10.1111/J.1471-4159.2007.05181.X |
0.457 |
|
| 2007 |
Dalrymple A, Wild EJ, Joubert R, Sathasivam K, Björkqvist M, Petersén A, Jackson GS, Isaacs JD, Kristiansen M, Bates GP, Leavitt BR, Keir G, Ward M, Tabrizi SJ. Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates. Journal of Proteome Research. 6: 2833-40. PMID 17552550 DOI: 10.1021/Pr0700753 |
0.321 |
|
| 2006 |
Björkqvist M, Petersén A, Bacos K, Isaacs J, Norlén P, Gil J, Popovic N, Sundler F, Bates GP, Tabrizi SJ, Brundin P, Mulder H. Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6/2 transgenic mouse model of Huntington's disease. Human Molecular Genetics. 15: 1713-21. PMID 16613897 DOI: 10.1093/Hmg/Ddl094 |
0.491 |
|
| 2005 |
Karlsson J, Petersén Å, Gidö G, Wieloch T, Brundin P. Combining Neuroprotective Treatment of Embryonic Nigral Donor Tissue with Mild Hypothermia of the Graft Recipient. Cell Transplantation. 14: 301-309. PMID 28866932 DOI: 10.3727/000000005783983089 |
0.568 |
|
| 2005 |
Papalexi E, Persson A, Björkqvist M, Petersén A, Woodman B, Bates GP, Sundler F, Mulder H, Brundin P, Popovic N. Reduction of GnRH and infertility in the R6/2 mouse model of Huntington's disease. The European Journal of Neuroscience. 22: 1541-6. PMID 16190907 DOI: 10.1111/J.1460-9568.2005.04324.X |
0.511 |
|
| 2005 |
Smith R, Petersén A, Bates GP, Brundin P, Li JY. Depletion of rabphilin 3A in a transgenic mouse model (R6/1) of Huntington's disease, a possible culprit in synaptic dysfunction. Neurobiology of Disease. 20: 673-84. PMID 15967669 DOI: 10.1016/J.Nbd.2005.05.008 |
0.501 |
|
| 2000 |
Petersén Å, Hansson O, Emgård M, Brundin P. Grafting of Nigral Tissue Hibernated with Tirilazad Mesylate and Glial Cell Line-Derived Neurotrophic Factor. Cell Transplantation. 9: 577-584. PMID 28880661 DOI: 10.1177/096368970000900503 |
0.736 |
|
| 2000 |
Petersen A, Hansson O, Emgård M, Brundin P. Grafting of nigral tissue hibernated with tirilazad mesylate and glial cell line-derived neurotrophic factor. Cell Transplantation. 9: 577-84. PMID 11144955 DOI: 10.1177/096368970000900503 |
0.744 |
|
| Show low-probability matches. |